Effectiveness of an Intervention on Vaccine Hesitancy Among Pediatric Nurses and Pediatricians

Brief summary (registry, in English)

The objective of this cluster randomized controlled trial is to assess the effectiveness of a multicomponent intervention designed to improve pediatric nurses' and pediatricians' knowledge, self-efficacy, communication skills, and practice administrative procedures and policies for promoting vaccines in the child and adolescent immunization schedule and addressing patient vaccine hesitancy. The main research questions are: * Does the intervention meet pediatric nurses' and pediatricians' educational needs regarding vaccination? * Does the intervention increase the use of presumptive communication by pediatric nurses and pediatricians during vaccine conversations? * Does the intervention enhance the confidence of pediatric nurses and pediatricians to effectively navigate conversations with vaccine-hesitant families? * Does the intervention enhance the abilities of pediatric nurses and pediatricians to effectively navigate conversations with vaccine-hesitant families? Participants assigned to the intervention group will complete a 12-hour, medically accredited, evidence-based training program focused on vaccination promotion. This training will be divided into two components: 10 hours of online education covering vaccines and vaccination communication strategies, and 2 hours of in-person activities involving role-playing and group discussions. Pediatric nurses and pediatricians assigned to the control group will continue with their usual practices. To assess the effectiveness of the intervention formative and pre/post summative evaluations with a mixed-methods approach will be carried out.

What you commit to

• Study type: Interventional
• Participants enrolled: 142
• From 1 Oct 2023 to the primary completion date, 29 Feb 2024
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: - to 67 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.